- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.03 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 2OD: 5'-methoxy-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclobutane-1,3'-indol]-2'-amine(Non-covalent)
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
SAH.2: 16 residues within 4Å:- Chain A: M.140, G.141, W.142, S.176, Y.177, R.201, F.202, I.203, N.204, H.205, Y.246, F.250, F.258, T.259, C.260, Q.261
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:M.140, A:W.142, A:W.142, A:N.204, A:H.205, A:H.205, A:Q.261
SAH.7: 16 residues within 4Å:- Chain B: M.140, G.141, W.142, S.176, Y.177, R.201, F.202, I.203, N.204, H.205, Y.246, F.250, F.258, T.259, C.260, Q.261
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:W.142, B:W.142, B:S.176, B:Y.177, B:Y.177, B:N.204, B:H.205, B:H.205, B:Q.261
- 8 x ZN: ZINC ION(Non-covalent)
ZN.3: 6 residues within 4Å:- Chain A: C.66, C.79, C.109, C.113
- Ligands: ZN.4, ZN.5
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.66, A:C.79, A:C.109, A:C.113
ZN.4: 7 residues within 4Å:- Chain A: C.66, C.68, C.72, C.77, C.109
- Ligands: ZN.3, ZN.5
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.66, A:C.68, A:C.72, A:C.77
ZN.5: 6 residues within 4Å:- Chain A: C.72, C.109, C.115, C.119
- Ligands: ZN.3, ZN.4
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:C.72, A:C.109, A:C.115, A:C.119, H2O.5
ZN.6: 4 residues within 4Å:- Chain A: C.207, C.260, C.262, C.267
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.207, A:C.260, A:C.262, A:C.267
ZN.9: 6 residues within 4Å:- Chain B: C.72, C.109, C.115, C.119
- Ligands: ZN.10, ZN.11
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.72, B:C.109, B:C.115, B:C.119
ZN.10: 7 residues within 4Å:- Chain B: C.66, C.68, C.72, C.77, C.109
- Ligands: ZN.9, ZN.11
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.66, B:C.68, B:C.72, B:C.77
ZN.11: 6 residues within 4Å:- Chain B: C.66, C.79, C.109, C.113
- Ligands: ZN.9, ZN.10
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.66, B:C.79, B:C.109, B:C.113
ZN.12: 4 residues within 4Å:- Chain B: C.207, C.260, C.262, C.267
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.207, B:C.260, B:C.262, B:C.267
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sweis, R.F. et al., Discovery and development of potent and selective inhibitors of histone methyltransferase g9a. ACS Med Chem Lett (2014)
- Release Date
- 2014-01-15
- Peptides
- Histone-lysine N-methyltransferase EHMT2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.03 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 2OD: 5'-methoxy-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclobutane-1,3'-indol]-2'-amine(Non-covalent)
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
- 8 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sweis, R.F. et al., Discovery and development of potent and selective inhibitors of histone methyltransferase g9a. ACS Med Chem Lett (2014)
- Release Date
- 2014-01-15
- Peptides
- Histone-lysine N-methyltransferase EHMT2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B